Clinical Trials Directory

Trials / Completed

CompletedNCT06029855

Kabat Rehabilitation Versus Mime Therapy on Facial Disability and Synkinesis in Patients of Bell's Palsy

Effects Of Kabat Rehabilitation Versus Mime Therapy On Facial Disability And Synkinesis In Patients Of Bell's Palsy

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
85 (actual)
Sponsor
University of Lahore · Academic / Other
Sex
All
Age
25 Years – 50 Years
Healthy volunteers
Not accepted

Summary

Bell's palsy, also called idiopathic facial paralysis, is a common cause of unilateral facial paralysis. It is one of the most common neurological disorders of the cranial nerves.

Detailed description

Bell's palsy is an alarming condition of rapid onset, which paralyzes half of the facial muscles. Kabat rehabilitation is a manual resistance technique that promotes a basic pattern of movement through facilitation, inhibition, and resistance of a group of muscles. It increases the functioning and power of facial muscles while Mime therapy results in immediate improvement of function and integrity of facial muscles. It also mitigates synkinesis in Bell's palsy. Both techniques are easy to apply. They are clinically important techniques that are easily understood by patients.

Conditions

Interventions

TypeNameDescription
OTHERKabat TherapyThe participants of group A will receive Kabat Rehabilitation with routine physical therapy. The protocol will be given to the participants for three sessions/week for six weeks. Each session will be of 30 minutes.
OTHERMime TherapyThe participants of group B will receive Mime Therapy in addition to routine physical therapy. The protocol will be given to the participants once a week for six weeks, while physical therapy will be given on alternate days. Each session will be of 30 minutes.

Timeline

Start date
2023-05-01
Primary completion
2023-09-30
Completion
2023-10-15
First posted
2023-09-08
Last updated
2025-03-28

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06029855. Inclusion in this directory is not an endorsement.